{"id":36763,"date":"2023-05-25T11:30:43","date_gmt":"2023-05-25T09:30:43","guid":{"rendered":"https:\/\/www.satt.fr\/?p=36763"},"modified":"2023-05-25T11:36:12","modified_gmt":"2023-05-25T09:36:12","slug":"sayens-clinisciences-signature-licence-exclusive","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/sayens-clinisciences-signature-licence-exclusive\/","title":{"rendered":"SATT Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive"},"content":{"rendered":"<p style=\"text-align: center;\"><span style=\"color: #c90f4c;\"><strong><span style=\"font-size: 24pt;\">Lutte contre le cancer :<br \/>un test g\u00e9n\u00e9tique sur biopsies solides et liquides d\u2019orientation vers des th\u00e9rapies contre le cancer<\/span><\/strong><\/span><\/p>\n<hr \/>\n<p style=\"text-align: center;\"><!--more--><\/p>\n<p>Invent\u00e9e \u00e0 Dijon au sein de la\u00a0<a href=\"https:\/\/www.cgfl.fr\/plateforme\/plateforme-de-transfert-biologie-cancerologique\/\" target=\"_blank\" rel=\"noopener\">Plateforme de Transfert en Biologie Canc\u00e9rologique<\/a>\u00a0(PTBC) de l\u2019universit\u00e9 de Bourgogne et plus particuli\u00e8rement de l\u2019unit\u00e9 de Biologie Mol\u00e9culaire du Centre de lutte contre le cancer\u00a0<a href=\"https:\/\/www.cgfl.fr\/\" target=\"_blank\" rel=\"noopener\">Georges-Fran\u00e7ois Leclerc<\/a>\u00a0(CGFL), la technologie a \u00e9t\u00e9 brevet\u00e9e, matur\u00e9e et transf\u00e9r\u00e9e par la SATT Sayens au Groupe CliniSciences, dans le cadre d\u2019une licence exclusive. Cette innovation offre la possibilit\u00e9 de d\u00e9tecter et d\u2019interpr\u00e9ter des mutations g\u00e9n\u00e9tiques, m\u00eame tr\u00e8s rares, dans du tissu tumoral ou du plasma sanguin dans le but de mieux orienter et donc de personnaliser la prise en charge m\u00e9dicamenteuse des patients atteints de cancers.<!--more--><\/p>\n<h2>Une innovation cl\u00e9 pour la m\u00e9decine personnalis\u00e9e soutenue par Sayens<\/h2>\n<p>A Les travaux des chercheurs <strong>Romain BOIDOT<\/strong>, <strong>Fr\u00e9d\u00e9rique VEGRAN<\/strong> et <strong>Fran\u00e7ois GHIRINGHELLI<\/strong>, ont \u00e9t\u00e9 accompagn\u00e9s par Sayens d\u00e8s 2018, prot\u00e9g\u00e9s par brevet et valid\u00e9s par CliniSciences. Cette invention a fait l\u2019objet d\u2019une publication scientifique2 portant sur l\u2019analyse de pr\u00e8s de 2300 patients sur 3 ans. Un travail avec la soci\u00e9t\u00e9 CliniSciences a permis d\u2019am\u00e9liorer le protocole afin de permettre une impl\u00e9mentation ais\u00e9e de la technologie dans de nombreux laboratoires au niveau international.<\/p>\n<p>Gr\u00e2ce \u00e0 cette licence, CliniSciences vise la production d\u2019un kit innovant de d\u00e9tection de mutations g\u00e9n\u00e9tiques, dans les biopsies solides et liquides en oncologie.<\/p>\n<p>L\u2019identification de ces mutations, par s\u00e9quen\u00e7age NGS, permettra d\u2019orienter le patient vers des m\u00e9dicaments poss\u00e9dant actuellement une Autorisation de Mise sur le March\u00e9 (AMM) conciliant ainsi rapidit\u00e9 dans la prise en charge des patients et gains \u00e9conomiques pour le syst\u00e8me de sant\u00e9.<\/p>\n<p>L\u2019objectif final de ce kit est d\u2019am\u00e9liorer le diagnostic mol\u00e9culaire th\u00e9ranostique dans le domaine de l\u2019oncologie, ainsi que la capacit\u00e9 des oncologues \u00e0 diagnostiquer et \u00e0 choisir la strat\u00e9gie th\u00e9rapeutique la plus adapt\u00e9e au patient.<\/p>\n<p>Pour\u00a0<strong>le Docteur Romain BOIDOT,\u00a0Responsable des activit\u00e9s de biologie mol\u00e9culaire au sein du CGFL et co-inventeur<\/strong>\u00a0<em>\u00ab nous attachons beaucoup d\u2019int\u00e9r\u00eat \u00e0 l\u2019innovation et donc voir nos travaux de recherche d\u00e9boucher sur un transfert technologique avec CliniSciences est une fiert\u00e9. La collaboration avec la SATT Sayens nous a permis d\u2019am\u00e9liorer encore le test au niveau du protocole lui-m\u00eame dans le but de faciliter son impl\u00e9mentation \u00e0 l\u2019international tout en conservant la robustesse et la fiabilit\u00e9 de notre test dont le but est d\u2019apporter une prise en charge personnalis\u00e9e des patients atteints de cancer \u00bb.<\/em><\/p>\n<p><em>\u00ab Nous nous r\u00e9jouissons de la concr\u00e9tisation du partenariat avec CliniSciences que nous esp\u00e9rons faire fructifier dans la dur\u00e9e. Gr\u00e2ce \u00e0 notre proximit\u00e9 avec la recherche publique, en tant que SATT, nous contribuons, \u00e0 faire \u00e9merger et \u00ab d\u00e9risquer \u00bb des innovations prometteuses afin de passer le relais aux industriels. Le continuum Recherche, Innovation et Industrie est ainsi assur\u00e9. Dans ce partenariat, nous d\u00e9montrons collectivement, que nous apportons \u00e0 la m\u00e9decine personnalis\u00e9e dans la lutte contre le cancer, des r\u00e9ponses concr\u00e8tes aux besoins actuels et futurs de notre syst\u00e8me de sant\u00e9, au b\u00e9n\u00e9fice des patients \u00bb\u00a0<\/em>indique\u00a0<strong>Catherine GUILLEMIN, Pr\u00e9sidente de Sayens<\/strong><\/p>\n<p><a href=\"https:\/\/www.sayens.fr\/actualites\/reussite\/clinisciences-licence\/\" target=\"_blank\" rel=\"noopener\">En savoir +<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lutte contre le cancer :un test g\u00e9n\u00e9tique sur biopsies solides et liquides d\u2019orientation vers des th\u00e9rapies contre le cancer<\/p>\n","protected":false},"author":34,"featured_media":36764,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[535,536],"tags":[],"class_list":["post-36763","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-reussites","category-actualite"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SATT Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive - R\u00e9seau SATT<\/title>\n<meta name=\"description\" content=\"Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive portant sur un test g\u00e9n\u00e9tique sur biopsies solides et liquides d\u2019orientation vers des th\u00e9rapies contre le cancer\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anthony Petit\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/\"},\"author\":{\"name\":\"Anthony Petit\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6a5a84617bc785ef388bd1eb3a23c650\"},\"headline\":\"SATT Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive\",\"datePublished\":\"2023-05-25T09:30:43+00:00\",\"dateModified\":\"2023-05-25T09:36:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/\"},\"wordCount\":589,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/05\/Image-Actu-Reseau-SATT-Clinisciences-scaled.jpg\",\"articleSection\":[\"R\u00e9ussites\",\"Actualit\u00e9\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/\",\"url\":\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/\",\"name\":\"SATT Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/05\/Image-Actu-Reseau-SATT-Clinisciences-scaled.jpg\",\"datePublished\":\"2023-05-25T09:30:43+00:00\",\"dateModified\":\"2023-05-25T09:36:12+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6a5a84617bc785ef388bd1eb3a23c650\"},\"description\":\"Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive portant sur un test g\u00e9n\u00e9tique sur biopsies solides et liquides d\u2019orientation vers des th\u00e9rapies contre le cancer\",\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/05\/Image-Actu-Reseau-SATT-Clinisciences-scaled.jpg\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/05\/Image-Actu-Reseau-SATT-Clinisciences-scaled.jpg\",\"width\":2560,\"height\":1564,\"caption\":\"Various types of cheese on the table\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SATT Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6a5a84617bc785ef388bd1eb3a23c650\",\"name\":\"Anthony Petit\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/anthony-petitsayens-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SATT Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive - R\u00e9seau SATT","description":"Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive portant sur un test g\u00e9n\u00e9tique sur biopsies solides et liquides d\u2019orientation vers des th\u00e9rapies contre le cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/","twitter_misc":{"Written by":"Anthony Petit","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/"},"author":{"name":"Anthony Petit","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6a5a84617bc785ef388bd1eb3a23c650"},"headline":"SATT Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive","datePublished":"2023-05-25T09:30:43+00:00","dateModified":"2023-05-25T09:36:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/"},"wordCount":589,"image":{"@id":"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/05\/Image-Actu-Reseau-SATT-Clinisciences-scaled.jpg","articleSection":["R\u00e9ussites","Actualit\u00e9"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/","url":"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/","name":"SATT Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/05\/Image-Actu-Reseau-SATT-Clinisciences-scaled.jpg","datePublished":"2023-05-25T09:30:43+00:00","dateModified":"2023-05-25T09:36:12+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6a5a84617bc785ef388bd1eb3a23c650"},"description":"Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive portant sur un test g\u00e9n\u00e9tique sur biopsies solides et liquides d\u2019orientation vers des th\u00e9rapies contre le cancer","breadcrumb":{"@id":"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/05\/Image-Actu-Reseau-SATT-Clinisciences-scaled.jpg","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2023\/05\/Image-Actu-Reseau-SATT-Clinisciences-scaled.jpg","width":2560,"height":1564,"caption":"Various types of cheese on the table"},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/sayens-clinisciences-signature-licence-exclusive\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"SATT Sayens et CliniSciences annoncent la signature d\u2019un contrat de licence exclusive"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6a5a84617bc785ef388bd1eb3a23c650","name":"Anthony Petit","url":"https:\/\/www.satt.fr\/en\/author\/anthony-petitsayens-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/36763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=36763"}],"version-history":[{"count":5,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/36763\/revisions"}],"predecessor-version":[{"id":36775,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/36763\/revisions\/36775"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/36764"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=36763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=36763"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=36763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}